Merck is in talks to buy cancer drugmaker Harpoon Therapeutics for about $700 million, or $23 per share, Bloomberg News reported, citing people familiar with.
Johnson & Johnson said Monday it has entered into a definitive agreement to acquire Ambrx Biopharma Inc. The all-cash merger transaction has a total equity.
Hilton Grand Vacations Inc. said Friday it’s planning an offering of $900 million of 8-year high-yield bonds as part of the financing for its acquisition of.
Synopsys Inc. is in advanced talks to acquire Ansys Inc. for about $35 billion in a $400 per share cash-and-stock deal that could be one of the first big.